InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（15 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
15
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Christianson Mark, Directeur du Développement Commercial. Insider active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. Cumulatively, 51 disclosures have been logged. Split: 0 buy · 15 sells. Total volume traded: €224k. History available since 23 June 2021. The latest transaction was disclosed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Christianson Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报51 总计
15,363 股@ US$0.744.8% 占其流量Common StockSEC:0001709738-26-000009:0
253 股@ US$0.7770.1% 占其流量Common StockSEC:0001709738-26-000009:1
817 股@ US$0.800.2% 占其流量Common StockSEC:0001709738-26-000008:0
11,611 股@ US$0.803.4% 占其流量Common StockSEC:0001709738-26-000007:0
1,812 股@ US$0.680.4% 占其流量Common StockSEC:0001709738-26-000006:0
253 股@ US$0.7580.1% 占其流量Common StockSEC:0001709738-26-000001:0
253 股@ US$0.88860.1% 占其流量Common StockSEC:0001709738-25-000011:0
30,000 股@ US$0.74018.4% 占其流量Common StockSEC:0001709738-25-000010:0
253 股@ US$0.6780.1% 占其流量Common StockSEC:0001709738-25-000008:0
10,000 股@ US$0.58042.6% 占其流量Common StockSEC:0001709738-25-000007:0
14 股@ US$0.650.0% 占其流量Common StockSEC:0001709738-25-000006:0
8,006 股@ US$0.66571.5% 占其流量Common StockSEC:0001709738-25-000005:0
253 股@ US$0.85020.1% 占其流量Common StockSEC:0001709738-25-000003:0
1,812 股@ US$1.160.6% 占其流量Common StockSEC:0001709738-25-000002:0
90 股@ US$1.150.0% 占其流量Common StockSEC:0001709738-25-000001:0
343 股@ US$0.8260.1% 占其流量Common StockSEC:0001213900-25-000717:0
90 股@ US$0.62310.0% 占其流量Common StockSEC:0001709738-24-000015:0
90 股@ US$0.970.0% 占其流量Common StockSEC:0001709738-24-000014:0
343 股@ US$0.990.1% 占其流量Common StockSEC:0001709738-24-000013:0
90 股@ US$0.79640.0% 占其流量Common StockSEC:0001709738-24-000012:0
90 股@ US$0.750.0% 占其流量Common StockSEC:0001709738-24-000011:0
343 股@ US$0.800.1% 占其流量Common StockSEC:0001709738-24-000010:0
2,189 股@ US$0.8760.6% 占其流量Common StockSEC:0001709738-24-000009:0
25,800 股@ US$0.87846.5% 占其流量Common StockSEC:0001709738-24-000008:0
90 股@ US$0.92990.0% 占其流量Common StockSEC:0001709738-24-000007:0
51 条申报中的 25 条
About Christianson Mark
Christianson Mark is Business Development Director and is associated with filings for NEUROONE MEDICAL TECHNOLOGIES Corp on XNAS. In total, 51 filings are recorded, and across the recent filings sampled, sales total EUR 224225 between 2021-06-25 and 2026-04-01, with the most frequent transaction nature indicated as Tax withholding.
